XBiotech Inc.

XBIT

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
XBIT
CIK0001626878
SIC2834
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupPharmaceutical Preparations

Contact

Address5217 WINNEBAGO LANE, AUSTIN, TX, 78744
Website xbiotech.com
Phone512-386-2900
CEOJohn Simard
Employees100

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$0.00
Pre-Tax Income$-45.30 million
Net Income$-45.54 million
Net Income to Common$-45.54 million
EPSN/A
View All
Balance Sheet
Cash$125.55 million
Assets$150.08 million
Liabilities$9.73 million
Common Equity$140.35 million
Liabilities & Equity$150.08 million
View All
Cash Flow Statement
Calculations
NOPAT$-38.98 million
EBITDA$-49.21 million
Price to EarningsN/A
Price to Book$0.53
ROEN/A
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

XBiotech: Q4 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Friday reported a loss of $26.9 million in its fourth quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 88 cents.

Article Link

3 Promising Penny Stocks With Market Caps Over $30M

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it still refers to shares of smaller or newer companies that can offer significant potential for growth. By focusing on those with solid financial foundations, investors can uncover opportunities that may provide stability and upside potential.

Article Link

November 2025's Promising Penny Stocks To Watch

As the Dow Jones Industrial Average reaches an all-time high amid optimism over the potential end of a prolonged U.S. government shutdown, investors are keenly observing market dynamics and seeking opportunities across various sectors. Penny stocks, often seen as a gateway to investing in smaller or emerging companies, continue to hold allure for those looking for growth at accessible price points. Despite their historical reputation for volatility, penny stocks with strong financials and...

Article Link

XBiotech: Q3 Earnings Snapshot

AUSTIN, Texas (AP) — XBiotech Inc. XBIT) on Wednesday reported a loss of $6 million in its third quarter. The Austin, Texas-based company said it had a loss of 20 cents per share.

Article Link

XBiotech Inc.'s (NASDAQ:XBIT) top owners are retail investors with 52% stake, while 36% is held by insiders

Key Insights Significant control over XBiotech by retail investors implies that the general public has more power to...

Article Link